LVAC | LAVA Medtech Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	10.42 - 10.44
52 Week Range	9.94 - 10.85
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	N/A
Average Volume	44,325
Shares Outstanding	14,374,999
Market Cap	149,931,240
Sector	Financial Services
Industry	Shell Companies
IPO Date	2021-12-17

Valuation
Profitability
Growth
Health
P/E Ratio	33.65
Forward P/E Ratio	N/A
EPS	0.31
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.

LVAC's peers: BRKH

*Chart delayed

Analyzing fundamentals for LVAC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see LVAC Fundamentals page.

Watching at LVAC technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on LVAC Technicals page.